|
|
|
Welcome Note
Yuval Yaron, Israel |
|
Session 1: Advances in Prenatal Diagnosis |
|
Prenatal diagnosis in the genomics era
Lyn Chitty, UK |
|
Whole exome sequencing for fetal brain anomalies
Yuval Yaron, Israel |
|
Debate – Should whole exome sequencing be offered to all pregnant women?
FOR: Ignatia van der Veyver, USA
AGAINST: Neeta Vora, USA
Moderator: Brynn Levy, USA |
|
The future of Prenatal Diagnosis
Ron Wapner, USA |
|
Whole genome sequencing for recurrent miscarriage
Richard Choy, Hong Kong |
|
Session 2: Sponsored satellite symposium- Perkin Elmer |
|
Introduction
Lotta Ulfstedt, Switzerland |
|
Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study)
Ritsuko Pooh, Japan |
|
cfDNA Accuracy Using Vanadis test in twin pregnancies during 1st trimester of pregnancy
Alexandre Vivanti, France |
|
Session 3: Non-Invasive Prenatal testing |
|
The benefits of genome-wide NIPT
Mark Pertile, Australia |
|
Circulating fetal cells to screen/diagnose monogenic diseases
Line Dahl Jeppesen, ARCEDI |
|
Session 4: Sponsored satellite symposium- Illumina |
|
The impact of the NIPT Insights App on patient preparedness for counselling conversations – A multi-site experience
Maria del Mar Gil, Spain & Miyuki Nishiyama, Japan |
|
Learnings of a multiyear experience with expanded cfDNA screening
Erica Soster, USA |
|
Session 5: Preimplantation genetic testing (PGT) |
|
Genomic determinant of human embryonic arrest
Antonio Capalbo, Italy |
|
Advances in non invasive embryo testing
Santiago Munne, Spain |
|
Can technological advances solve the challenges of PGT-A
Tony Gordon, CooperSurgical |
|
Making sense of Mosaicism in PGT-A
Manuel Viotti, USA |
|
Expanded carrier screening as a gateway to PGT-M
Avner Hershlag, USA
Supported by Sema4 |
|
Closing remarks
Yuval Yaron, Israel |
|
|
